Covid -19

Diagosis and treatment protocol for COVID19 patients
(Tentative 10th Version)
(2023, China)

Released by National Health Commission of People’s Republic of China & National Administration of Traditional Chinese Medicine on January 5, 2023.

11.8 | Traditional Chinese medicine (TCM) therapy
This disease belongs to plague in TCM,
caused by epidemic pathogenic factors.
According to the different local climate characteristics and individual states of illness and physical conditions,
the following treatment Protocol may vary. …

https://onlinelibrary.wiley.com/doi/epdf/10.1002/hcs2.36

Zhang Z. Diagnosis and treatment protocol for COVID19 patients (Tentative 10th Version). Health Care Sci. 2023;2:10–24.
https://doi.org/10.1002/hcs2.36

Therapeutic drug combinations against COVID-19
obtained by employing a collaborative filtering method

(2023, China)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958039/pdf/main.pdf

TCM can effectively treat COVID-19, decrease the conversion
of mild cases to severe cases, shorten the virus clearance time,
and improve the clinical prognosis of mild and common COVID-19 patients

In March 2020, the State Medical Products Administration announced that Jinhua Qinggan Granules will be converted
from prescription drugs to Class A  non-prescription drugs.

Jinhua Qinggan Granules can be used for fever, cough, and malaise caused by viral infection,
in addition to being used for the routine treatment of
novel coronavirus pneumonia.

The antipyretic and antiviral effects of Jinhua Qinggan Granules can effectively ameliorate the clinical symptoms of COVID-19 patients.
Jinhua Qinggan Granules acted on PTGS2, TNF-α, NF-κB, IL-6, and CASP-8 targets and exerted anti-COVID-19 effects through Toll-like receptor signaling pathways.

The State Food and Drug Administration issued supplementary approval in May 2020,
Jinhua Qinggan granule is suitable for the treatment
of mild and common types of novel coronavirus pneumonia.

On March 31, 2022, the World Health Organization (WHO) released the “World Health Organization Expert Evaluation Meeting on Traditional Chinese Medicine against COVID-19”
on its official website, which fully affirmed the contribution of TCM in fighting the epidemic situation of COVID-19.

ALASELJAVALU

Nõelravi radikulaarse valu ravis (2024, Hiina)

https://www.frontiersin.org/articles/10.3389/fnmol.2024.1332876/full
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11002172/pdf/fnmol-17-1332876.pdf

Nõelravi vähendab oluliselt põletikulist, neuropaatilist ja
radikulaarset valu, põhjustab vähe kõrvaltoimeid ning
on kuluefektiivne.

Radikulaarse (närvijuurtest lähtuva) valu tähtsaim põhjus
on närvijuurte kompressioon.
Selle põhjusteks võivad olla lülidevahelise ketta (diski)
väljasopistumine, spinaalstenoos või lülisamba degeneratsioon.
Valu intensiivsus ei korreleeru alati kompressiooni ulatusega,
oma roll ka põletikul.

Sageli eelistatakse kirurgilist ravi konservatiivsele,
sest see annab kiirema leevenduse.
Kuid 1 aasta hiljem on kirurgilise ja konservatiivse ravi
tulemuste vaheline erinevus minimaalne.
Kuna ravi kaugtulemuste erinevus on väike, 
tuleks kirurgilist ravi soovitada põhiliselt
raviresistentsuse ja väga tugeva valu puhul.

Nõelravi on efektiivsem kui ravivõimlemine.
Ravimid põhjustavad sageli kõrvaltoimeid.

Nõelravi lõõgastab lihasspasmi,
vähendab mehhaanilist survet närvijuurtele,
parandab mikrotsirkulatsiooni ja omab põletikuvastast toimet
(teatud molekulaarsete signaalradade pidurdamise kaudu
vähendab proinflammatoorsete tsütokiinide vabanemist),
mille abil leevendab radikulaarset valu.

Nõelravi tsentraalsed analgeetilised toimed on seotud
selja- ja peaaju valu töötlemisega seotud struktuuride ning
nende omavaheliste ühenduste mõjutamisega.

Acupuncture for radicular pain: a review of analgesic mechanism (2024, China)

Ägeda/alaägeda mittespetsiifilise alaseljavalu ravis
on nõelravi efektiivsem ja ohutum kui suukaudsed ravimid (2023, Hiina)
Acupuncture Versus Oral Medications for Acute/Subacute Non‑Specific Low Back Pain:
A Systematic Review and Meta‑Analysis (2023, China)

https://pubmed.ncbi.nlm.nih.gov/38190024/
Current Pain and Headache Reports
https://doi.org/10.1007/s11916-023-01201-7

Acupuncture and Spinal Stenosis: Considerations for Treatment (2022, USA)
Compared to no treatment, sham acupuncture, or usual therapy,
acupuncture has a significantly superior effect on the reduction in pain
and functional limitations for patients with chronic spinal pain.
Our results suggest that acupuncture is also a safe therapy.
Patients with chronic spinal pain might benefit from acupuncture therapy.
https://pdfs.semanticscholar.org/
4160/5af1c0cbfd6a2473139d899b5df73473a2f0.pdf

Can Acupuncture Improve Chronic Spinal Pain? (2021, China)
Global Spine Journal
Conclusion:
In summary, compared to no treatment, sham acupuncture,
or conventional therapy such as medication, massage, and physical exercise,
acupuncture has a significantly superior effect
on the reduction in chronic spinal pain and function improvement.
Acupuncture might be an effective treatment for patients
with chronic spinal pain and it is a safe therapy.
https://pubmed.ncbi.nlm.nih.gov/33034233/

Alates 2020. a tasub USA ravikindlustus nõelravi eest kroonilise alaseljavalu puhul.